Seeking Alpha

  InVivo Therapeutics Holdings Corp (NVIV) - OTCQB

  • Herbert Samuel Jennings | Send Message 26 Dec 2013

    Major news for $NVIV. The FDA just granted conditional approval for human testing the scaffold. It would appear NVIV is back on track!
    Reply
      NVIV vs. ETF Alternatives
      Company Description
      InVivo Therapeutics Holdings Corp. is a pioneering biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, ScD., Professor at Massachusetts Institute of Technology, and... More
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States